FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-517 | 83298-517-10 | Oxytocin | 30 [USP'U]/3 mL | 2026-1 | valid | 2026-10-06 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 83298-517 | 83298-517-10 | Oxytocin | Oxytocin | 30 [USP'U]/3 mL | 2026-1 | valid | 2026-09-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-517 | 83298-517-10 | Oxytocin | 30 [USP'U]/3 mL | 2025-2 | valid | 2026-10-06 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 83298-517 | 83298-517-10 | Oxytocin | Oxytocin | 30 [USP'U]/3 mL | 2025-2 | valid | 2026-09-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-517 | 83298-517-10 | Oxytocin | 10 [USP'U]/1 mL | 2025-1 | valid | 2026-10-06 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 83298-517 | 83298-517-10 | Oxytocin | Oxytocin Injection | 10 [USP'U]/1 mL | 2025-1 | valid | 2026-09-18 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 118916218 | 83298-517 | 83298-517-10 | Oxytocin | 10 [USP'U]/1 mL | 2024-2 | valid | 2026-10-06 | |
| Mark Cuban Cost Plus Manufacturing and Compounding LLC | 83298-517 | 83298-517-10 | Oxytocin | Oxytocin Injection | 10 [USP'U]/1 mL | 2024-2 | valid | 2026-09-18 |